Back
NewAmsterdam Pharma Co NV Stock Predictions
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
NAMS
NewAmsterdam Pharma Co NV
Last Price:
15.90
Seasonality Move:
4.65%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.NewAmsterdam Pharma Co NV Stock Forecast
- Over the next 52 weeks, NewAmsterdam Pharma Co NV has on average historically risen by 20.1% based on the past 3 years of stock performance.
- NewAmsterdam Pharma Co NV has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is NewAmsterdam Pharma Co NV Stock Undervalued?
The current NewAmsterdam Pharma Co NV [NAMS] share price is $15.88. The Score for NAMS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal. - NAMS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will NewAmsterdam Pharma Co NV Stock Go Up Next Year?
- Over the next 52 weeks, NewAmsterdam Pharma Co NV has on average historically risen by 20.1% based on the past 3 years of stock performance.
NewAmsterdam Pharma Co NV Stock Rating
Sell
23
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
Is NewAmsterdam Pharma Co NV overpriced?
- NewAmsterdam Pharma Co NV has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
NewAmsterdam Pharma Co NV Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Netherlands
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
newamsterdampharma.com
52-Week Data
52-Week High:
26.35
52-Week Low:
5.63
Prediction Charts
Market Cap:
1.43B
Price in USD:
15.88
Volume:
75.59K
Beta:
0.00
Technical Analysis
SMA50:
16.99
SMA100:
18.45
SMA200:
18.51
52-Wk Change:
60.57%
Stock Predictions
-
Is NewAmsterdam Pharma Co NV stock public?
Yes, NewAmsterdam Pharma Co NV is a publicly traded company. -
What is the NewAmsterdam Pharma Co NV stock quote today?
The NewAmsterdam Pharma Co NV stock price is 15.88 USD today. -
How to buy NewAmsterdam Pharma Co NV stock online?
You can buy NewAmsterdam Pharma Co NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-3 | 16.34 | 15.91 | 16.86 | 15.68 |
| Sep-4 | 15.84 | 16.02 | 16.47 | 15.82 |
| Sep-5 | 15.95 | 16.21 | 16.62 | 15.80 |
| Sep-6 | 16.33 | 16.41 | 16.61 | 15.72 |
| Sep-9 | 16.54 | 16.87 | 17.33 | 16.37 |
| Sep-10 | 17.01 | 16.47 | 17.25 | 15.93 |
| Sep-11 | 16.48 | 16.16 | 16.74 | 16.10 |
| Sep-12 | 16.04 | 15.97 | 16.61 | 15.94 |
| Sep-13 | 16.06 | 15.96 | 16.24 | 15.84 |
| Sep-16 | 16.06 | 15.84 | 16.36 | 15.84 |
| Sep-17 | 15.91 | 15.45 | 16.07 | 15.38 |
| Sep-18 | 15.49 | 15.95 | 16.25 | 15.32 |
| Sep-19 | 16.14 | 16.06 | 16.78 | 15.98 |
| Sep-20 | 16.06 | 15.88 | 16.15 | 15.87 |
NewAmsterdam Pharma Co NV Earnings
NewAmsterdam Pharma Co NV Earnings Report: Per Share NewAmsterdam Pharma Co NV Earnings Q1 Q2 Q3 and Q4 last year and next year.
NewAmsterdam Pharma Co NV Forecast Revenue Growth
NewAmsterdam Pharma Co NV Stock Analysis: Historical quarterly revenues per share for NewAmsterdam Pharma Co NV and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.19 per share, and an increase next year of $0.67 per share.
* NewAmsterdam Pharma Co NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.